Paradigm Biopharmaceuticals Ltd (PAR)

Sydney
2.00
-0.14(-6.54%)
  • Volume:
    680,955
  • Bid/Ask:
    1.97/2.01
  • Day's Range:
    1.88 - 2.12

PAR Overview

Prev. Close
2.14
Day's Range
1.88-2.12
Revenue
9.44M
Open
2.12
52 wk Range
0.86-2.69
EPS
-0.19
Volume
680,955
Market Cap
459.13M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
389,439
P/E Ratio
-
Beta
2.09
1-Year Change
1.58%
Shares Outstanding
234,249,228
Next Earnings Date
-
What is your sentiment on Paradigm Biopharmaceuticals Ltd?
or
Vote to see community's results!

Paradigm Biopharmaceuticals Ltd News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Paradigm Biopharmaceuticals Ltd Company Profile

Paradigm Biopharmaceuticals Ltd Company Profile

Employees
0
Market
Australia

Paradigm Biopharmaceuticals Limited is a late-stage drug development company. The Company is developing and commercializing injectable Pentosan Polysulfate Sodium (PPS) for the treatment of pain associated with musculoskeletal disorders driven by injury, inflammation, aging, degenerative disease, infection, or genetic predisposition. The Company focuses on repurposing PPS for the treatment of Osteoarthritis (OA) and bone marrow lesions (BML), chronic heart failure (CHF) and alphaviral arthritis (Ross River Virus and Chikungunya). Its product candidate PPS is a non-opioid drug treatment for the chronic pain and joint stiffness of Osteoarthritis. Its product candidate PPS is providing treatment for Mucopolysaccharidosis, an inherited defect in the catabolism of sulfated components of connective tissue known as glycosaminoglycans (GAGs). Its product candidate PPS is used to treat Ross River virus and Chikungunya, an arthritogenic alphaviruses transmitted by mosquito bites.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyStrong BuyBuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuySellStrong BuyNeutral
SummaryStrong BuyStrong BuyNeutralStrong BuyBuy
  • Hi everyone. Im a newby & was wondering if Paradigm would be a good investment over the long term? Any recomendations would greatly appreaciated
    0
    • For a long time investment stay with bluechips . PAR is a volitile stock
      0
  • Any recommendations for buying PAR
    0
    • buy
      0
  • Hi everyone
    0